I still think I think the crux of the matter is that the EMA has not previously dealt with a 'device' that also has pharmaceutical action.The fact that they have been forced by legal means to accept the device classification does not help either.
TIS Price at posting:
18.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.